Received: from WA1P291CA0011.POLP291.PROD.OUTLOOK.COM (2603:10a6:1d0:19::8) by DU4PR02MB11027.eurprd02.prod.outlook.com (2603:10a6:10:588::10) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.496.21; Mon, 12 Oct 2026 08:06:31 +0000 Received: from WA1PEPF00009B3C.eurprd05.prod.outlook.com (2603:10a6:1d0:19:cafe::9c) by WA1P291CA0011.outlook.office365.com (2603:10a6:1d0:19::8) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.472.22 via Frontend Transport; Mon, 12 Oct 2026 08:06:30 +0000 Received: from westeu11-emailsignatures-cloud.codetwo.com (20.93.157.195) by WA1PEPF00009B3C.mail.protection.outlook.com (10.167.242.42) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.522.6 via Frontend Transport; Mon, 12 Oct 2026 08:06:29 +0000 Received: from DU4PR02MB11027.eurprd02.prod.outlook.com (2603:10a6:10:588::10) by VI1PR02MB5024.eurprd02.prod.outlook.com with HTTPS; Mon, 12 Oct 2026 08:06:36 +0000 Received: from DU0PR02MB8782.eurprd02.prod.outlook.com ([fe80::d:e804:c51c:2f37]) by DU0PR02MB8782.eurprd02.prod.outlook.com ([fe80::d:e804:c51c:2f37%5]) with mapi id 15.21.0496.018; Mon, 12 Oct 2026 08:06:24 +0000 Received: from DU0PR02MB8782.eurprd02.prod.outlook.com (2603:10a6:10:412::7) by DB9PR02MB6636.eurprd02.prod.outlook.com (2603:10a6:10:213::21) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.496.21; Mon, 12 Oct 2026 08:06:24 +0000 Received: from DB6PR07CU003.outbound.protection.outlook.com (40.93.64.95) by westeu11-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Mon, 12 Oct 2026 08:06:28 +0000 From: "Janne Sepp - RA" To: =?iso-8859-1?Q?K=E4rolin_Jenas_-_RA?= References: In-Reply-To: Subject: Ed: Ravimituru andmed Date: Mon, 12 Oct 2026 11:06:24 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_022E_01DD5CA3.2C623080" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQJb98GQ23k0lLIq3L+hW7AyMX8OcQHZ6y6v Authentication-Results: mx.microsoft.com 1; spf=pass (sender IP is 20.93.157.195) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=pass action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 12 Oct 2026 08:06:29.6439 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 68849239-ffae-46ed-3235-08df2837b8ab X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: DU0PR02MB8782:EE_|DB9PR02MB6636:EE_|WA1PEPF00009B3C:EE_|DU4PR02MB11027:EE_|VI1PR02MB5024:EE_ X-MS-Exchange-Organization-AuthSource: DU0PR02MB8782.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: 68849239-ffae-46ed-3235-08df2837b8ab X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|39142699007|366016|31052699007|23010399003|35042699022|82310400026|56012099006|11063799006|261009223027099003|260925021311599003|260925021911599003|260925022911599003|10067099003|22082099003|55112099003|18002099003|13003099007|8096899003|41050700001; X-Forefront-Antispam-Report: CIP:20.93.157.195;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu11-emailsignatures-cloud.codetwo.com;PTR:westeu11-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(39142699007)(366016)(31052699007)(23010399003)(35042699022)(82310400026)(56012099006)(11063799006)(261009223027099003)(260925021311599003)(260925021911599003)(260925022911599003)(10067099003)(22082099003)(55112099003)(18002099003)(13003099007)(8096899003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 12 Oct 2026 08:06:29.4993 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 68849239-ffae-46ed-3235-08df2837b8ab X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: DU0PR02MB8782.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-Transport-CrossTenantHeadersStamped: DB9PR02MB6636 X-MS-Exchange-Transport-CrossTenantHeadersStamped: DU4PR02MB11027 X-MS-Exchange-Transport-EndToEndLatency: 00:00:07.2892602 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0496.018 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009284)(140003); X-Microsoft-Antispam-Message-Info: RtiHK1yzJYsfBwowGfWBIh+ldoMtH2FvfeEJy2U1t2QyqUshu61UUCvVcC84GwCw87sb5/v8FPwMbwnV9mYcZzHUzLm/JNXCXz2/ku1sTC0b5ECpHTFxI6S3ir/KR9ySJF6z76625EOPRiE2tHtT268w6ZpNrGSulKJUhjuncSoSXWsObueHpR7IuGhuDL6sL1xVUxss5xmcS7+qfsn4GSrvy+VIDU+pbLoEC2l6mjAXorYm8ZylSP0TCbSKV0rKFv3zoZtxR24kw2qc5qqJflT+7BczxXb61OHOKCmtRuhn5c2g4uFIbumPUnaJT5bgMP/c2SELk+z0LQI3H11PG8p5gLQbcYy6NS4RmTqGw1+DN40+iEMqtcQAdP/KkKCwluAJ1XsndcBXLvLZUaOr/bjP/WCnrVmmsz+k6r0oAnH9NBok3SDPtkgm6kfXGsju6KzCHhnoD+yglWvxZGibehalAWdYrMAxRBtzf4msCEeliHcTZDGAPInlbY5/TwEJr2TLEgmfGYxjwKJPHQIKz/gLSCDpLixIMdfaOtM1j4rN0wkXVigCh/sbsnb2ZO/9V3FMP3cIDcIoZ1prGiHmJfcTjfBUUblRPfRl7Ty+orHrl/TseaxVyVeeBNDBxIY3CPfPZfCU9cnzXfPqlID3sLiBZ2sLMsidbOkXSgYuE0jxy0PpVr2OjN/GvJJFVrESCkW7GJ80FhA8lIGMsNouaRqArODUr9lfr9ge9DDKKLW4ejQX3/I6xBSjKwf7OL3F/2H3wv5vrAQorymtS9o6L1yTFMY1FEzO2carrEoys2MV0/Jj75zYf8Ph2qYosid0MPs35Cm8UbpFnlcr0kBrJgiTc5BjYMlztNtnBFLAkmqSzn6/Cvq42ZxpE6wbKmcv4xQrZxR5G/Kz7G6BIhOtwA== Content-Language: et x-ms-exchange-organization-originalclientipaddress: 195.50.223.125 x-ms-exchange-organization-originalserveripaddress: 10.167.242.42 received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 20.93.157.195 as permitted sender) receiver=protection.outlook.com; client-ip=20.93.157.195; helo=westeu11-emailsignatures-cloud.codetwo.com; pr=C X-OlkEid: 00000000354180B9476080459B05E1BF834B446F070034AD76187591974DBF6C4F76951C873A01000200000000002495DA25D80D98438130990BFAFE78050000000007EC000039E9218892917C4780D4B98C9148DA42 X-MS-Has-Attach: X-MS-TNEF-Correlator: X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|366016|31052699007|39142699007|23010399003|261009223027099003|56012099006|260925022911599003|260925021311599003|260925021911599003|11063799006|10067099003|18002099003|22082099003|55112099003|13003099007|8096899003|41050700001; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:DU0PR02MB8782.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(366016)(31052699007)(39142699007)(23010399003)(261009223027099003)(56012099006)(260925022911599003)(260925021311599003)(260925021911599003)(11063799006)(10067099003)(18002099003)(22082099003)(55112099003)(13003099007)(8096899003)(41050700001);DIR:INT; X-Exchange-RoutingPolicyChecked: gSovnwK2al8SwHvyY80heevBvUi4yMoEO/frLMxNber31qa5Vn2Di/sKMzsQvr1Ij8VmXDkuO6jIFdelRC8Uzqa25GxzLPZ22Zq92lBvItE3kaih/CIYDEX0u7axuwq+tEPJskhbxVVpu91fBNI+gYxYfRcep2PgclYmEfnHsJyNR6w3NXC1E+aNcW9n+t/7MbZfTZ9tZg/Bu3fqRVRgqZRe0TgWIyl1cUKpWUa49St/uIr4u/DJ2xMwlBWQ9x9bwzMGDwdmJhUPzIR4KU3fpWQPA4Qmfbu4uHyAlcXypxqCI89UApAEMBqa6oEH6WTuMTaj5TC2upEl/pdDclQ5Vg== X-OrganizationHeadersPreserved: DB9PR02MB6636.eurprd02.prod.outlook.com X-CodeTwo-MessageID: 8de9763f-dadb-4925-8e84-d7c5e19a0550.20261012080628@westeu11-emailsignatures-cloud.codetwo.com X-CodeTwoProcessed: true X-MS-Exchange-Organization-AuthMechanism: 04 X-CrossPremisesHeadersPromoted: WA1PEPF00009B3C.eurprd05.prod.outlook.com X-CrossPremisesHeadersFiltered: WA1PEPF00009B3C.eurprd05.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersStripped: WA1PEPF00009B3C.eurprd05.prod.outlook.com X-OriginatorOrg: m1wmgpm3xrpm87txzdfw82by7.smtp.codetwo.online X-MS-Office365-Filtering-Correlation-Id-Prvs: 8bebe9ce-6ee8-453a-19e7-08df2837b5d3 X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[20.93.157.195];Helo=[westeu11-emailsignatures-cloud.codetwo.com] acceptlanguage: en-150, et-EE, en-GB, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-10-12T08:06:24.355Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; authentication-results-original: mx.microsoft.com 1; dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; This is a multipart message in MIME format. ------=_NextPart_000_022E_01DD5CA3.2C623080 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: 8bit _____ Saatja: Liisbet Aland (EE) Saadetud: esmaspäev, 5. oktoober 2026 13:42 Adressaat: Janne Sepp - RA Teema: Ravimituru andmed Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere Nagu eelnevalt telefonis rääkisime, soovin paluda täiendavaid andmeid humaanravimite käibe kohta. Meil on analüüsi jaoks vaja arvutada ravimite keskmine hind ühe defineeritud päevadoosi (DDD) kohta ATC-rühmade lõikes. Selleks oleks suureks abiks humaanravimite käibe statistika ATC-rühmade lõikes 2024. ja 2025. aasta kohta. Võimaluse korral sooviksime andmetes eristada ka retsepti- ja käsimüügiravimeid. Kui võimalik, palun edastada andmed sellise ATC detailsusega, mille kohta on olemas ka vastavad DDD andmed, et käibe ja ravimikasutuse andmeid oleks võimalik omavahel siduda. Samuti, kui Teie hinnangul on Ravimiametil veel muid asjakohaseid andmeid, mis võiksid selle analüüsi jaoks olulised olla, kuid mida ma ei ole päringus eraldi välja toonud, oleksin väga tänulik ka nende edastamise või neile viitamise eest. Andmed sobivad näiteks Exceli või CSV-vormingus. Ette tänades Liisbet Aland PwC | Konsultant | Ärikonsultatsioonid Email: liisbet.aland@pwc.com Mob: +372 55600416 | Tel: +372 614 1800 AS PricewaterhouseCoopers Advisors Tatari 1, 10116 Tallinn, Estonia pwc.com/ee | @PwC_EE | ee_info@pwc.com "Privacy Statement (hyperlink: https://www.pwc.com/ee/en/home/privacy-statements.html) The information transmitted is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon, this information by persons or entities other than the intended recipient is prohibited. If you received this in error, please contact the sender and delete the material from any computer. Please familiarize yourself with our privacy policy." ------=_NextPart_000_022E_01DD5CA3.2C623080 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable

Saatja: Liisbet Aland = (EE) <liisbet.aland@pwc.com>
Saadetud: esmasp=E4ev, 5. oktoober 2026 13:42
Adressaat: Janne Sepp - RA <janne.sepp@ravimiamet.ee>
Teema: Ravimituru andmed
 

T=E4helepanu! Tegemist on v=E4lisv=F5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.
Tere

Nagu eelnevalt telefonis r=E4=E4kisime, soovin paluda t=E4iendavaid = andmeid humaanravimite k=E4ibe kohta.

Meil on anal=FC=FCsi jaoks vaja arvutada ravimite keskmine hind =FChe = defineeritud p=E4evadoosi (DDD) kohta ATC-r=FChmade l=F5ikes. Selleks = oleks suureks abiks humaanravimite k=E4ibe statistika ATC-r=FChmade = l=F5ikes 2024. ja 2025. aasta kohta. V=F5imaluse korral sooviksime = andmetes eristada ka retsepti- ja k=E4sim=FC=FCgiravimeid.

Kui v=F5imalik, palun edastada andmed sellise ATC detailsusega, mille = kohta on olemas ka vastavad DDD andmed, et k=E4ibe ja ravimikasutuse = andmeid oleks v=F5imalik omavahel siduda.

Samuti, kui Teie hinnangul on Ravimiametil veel muid asjakohaseid = andmeid, mis v=F5iksid selle anal=FC=FCsi jaoks olulised olla, kuid mida = ma ei ole p=E4ringus eraldi v=E4lja toonud, oleksin v=E4ga t=E4nulik ka = nende edastamise v=F5i neile viitamise eest. Andmed sobivad n=E4iteks Exceli v=F5i CSV-vormingus. 


Ette t=E4nades

Liisbet Aland 
PwC | Konsultant | =C4rikonsultatsioonid   
Mob: +372 55600416 | Tel: +372 614 1800 
AS PricewaterhouseCoopers Advisors 
Tatari 1, 10116 Tallinn, Estonia 

"Privacy Statement (hyperlink: = https://www.pwc.com/ee/en/home/privacy-statements.html) The information = transmitted is intended only for the person or entity to which it is = addressed and may contain confidential and/or privileged material. Any = review, retransmission, dissemination or other use of, or taking of any action in reliance = upon, this information by persons or entities other than the intended = recipient is prohibited. If you received this in error, please contact = the sender and delete the material from any computer. Please familiarize yourself with our privacy policy."
------=_NextPart_000_022E_01DD5CA3.2C623080--